Literature DB >> 12041916

Low-iodine diet in the treatment of differentiated thyroid cancer with radioactive iodine.

Martin Sonenberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12041916     DOI： 10.1385/ENDO:17:2:141

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  13 in total

1.  THE EFFECT OF ACUTE IODIDE DEPLETION ON THYROID FUNCTION IN MAN.

Authors:  R M BARAKAT; S H INGBAR
Journal:  J Clin Invest       Date:  1965-07       Impact factor: 14.808

2.  Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.

Authors:  P W Ladenson; L E Braverman; E L Mazzaferri; F Brucker-Davis; D S Cooper; J R Garber; F E Wondisford; T F Davies; L J DeGroot; G H Daniels; D S Ross; B D Weintraub
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

3.  Thyrotropin and thyroglobulin as an index of optimal iodine intake: correlation with iodine excretion of 39,913 euthyroid patients.

Authors:  W Buchinger; O Lorenz-Wawschinek; G Semlitsch; W Langsteger; G Binter; R M Bonelli; O Eber
Journal:  Thyroid       Date:  1997-08       Impact factor: 6.568

4.  Low iodine diet in I-131 ablation of thyroid remnants.

Authors:  H R Maxon; S R Thomas; A Boehringer; J Drilling; M I Sperling; J C Sparks; I W Chen
Journal:  Clin Nucl Med       Date:  1983-03       Impact factor: 7.794

Review 5.  Detection of residual and recurrent thyroid cancer by radionuclide imaging.

Authors:  H R Maxon
Journal:  Thyroid       Date:  1999-05       Impact factor: 6.568

6.  Mannitol augmentation of I-131 uptake in the treatment of thyroid carcinoma.

Authors:  J I Hamburger; P Desai
Journal:  Metabolism       Date:  1966-12       Impact factor: 8.694

Review 7.  Recombinant human thyrotropin in the management of thyroid cancer.

Authors:  I R McDougall; R J Weigel
Journal:  Curr Opin Oncol       Date:  2001-01       Impact factor: 3.645

8.  Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer.

Authors:  J M Durski; R J Weigel; I R McDougall
Journal:  Nucl Med Commun       Date:  2000-06       Impact factor: 1.690

9.  A simplified low iodine diet in I-131 scanning and therapy of thyroid cancer.

Authors:  M Lakshmanan; A Schaffer; J Robbins; J Reynolds; J Norton
Journal:  Clin Nucl Med       Date:  1988-12       Impact factor: 7.794

10.  Influence of triiodothyronine withdrawal time on 131I uptake postthyroidectomy for thyroid cancer.

Authors:  J M Goldman; B R Line; R L Aamodt; J Robbins
Journal:  J Clin Endocrinol Metab       Date:  1980-04       Impact factor: 5.958
View more
  4 in total

Review 1.  Initial treatment of pediatric differentiated thyroid cancer: a review of the current risk-adaptive approach.

Authors:  Marguerite T Parisi; Hedieh Khalatbari; Sanjay R Parikh; Adina Alazraki
Journal:  Pediatr Radiol       Date:  2019-10-16

2.  Challenging cases in thyroid cancer: a multidisciplinary approach.

Authors:  Michael Tuttle; Richard Robbins; Steven M Larson; H William Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-10       Impact factor: 9.236

3.  Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy.

Authors:  Bart de Keizer; Boudewijn Brans; Anne Hoekstra; Pierre M J Zelissen; Hans P F Koppeschaar; Cees J M Lips; Peter P van Rijk; Rudi A Dierckx; John M H de Klerk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-12-19       Impact factor: 9.236

Review 4.  Pediatric papillary thyroid cancer: current management challenges.

Authors:  Frederik A Verburg; Hanneke M Van Santen; Markus Luster
Journal:  Onco Targets Ther       Date:  2016-12-28       Impact factor: 4.147
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.